Application 207625
- Type
- ANDA
- Sponsor
- AUROBINDO PHARMA LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LEVALBUTEROL HYDROCHLORIDE | LEVALBUTEROL HYDROCHLORIDE | SOLUTION;INHALATION | EQ 0.0103% BASE | No | No |
| 002 | LEVALBUTEROL HYDROCHLORIDE | LEVALBUTEROL HYDROCHLORIDE | SOLUTION;INHALATION | EQ 0.021% BASE | No | No |
| 003 | LEVALBUTEROL HYDROCHLORIDE | LEVALBUTEROL HYDROCHLORIDE | SOLUTION;INHALATION | EQ 0.042% BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A207625-001 | LEVALBUTEROL HYDROCHLORIDE | LEVALBUTEROL HYDROCHLORIDE | EQ 0.0103% BASE | SOLUTION / INHALATION | AN | 2016-12-30 | |
| A207625-002 | LEVALBUTEROL HYDROCHLORIDE | LEVALBUTEROL HYDROCHLORIDE | EQ 0.021% BASE | SOLUTION / INHALATION | AN | 2016-12-30 | |
| A207625-003 | LEVALBUTEROL HYDROCHLORIDE | LEVALBUTEROL HYDROCHLORIDE | EQ 0.042% BASE | SOLUTION / INHALATION | AN | 2016-12-30 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A207625-001 | AN |
| A207625-002 | AN |
| A207625-003 | AN |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A207625-001 | LEVALBUTEROL HYDROCHLORIDE | EQ 0.0103% BASE | SOLUTION / INHALATION | AN | 2016-12-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A207625-002 | LEVALBUTEROL HYDROCHLORIDE | EQ 0.021% BASE | SOLUTION / INHALATION | AN | 2016-12-30 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A207625-003 | LEVALBUTEROL HYDROCHLORIDE | EQ 0.042% BASE | SOLUTION / INHALATION | AN | 2016-12-30 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A207625-001 | AN | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A207625-002 | AN | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A207625-003 | AN | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levalbuterol | LEVALBUTEROL | Luoxin Aurovitas Pharma (Chengdu) Co., Ltd. | 29eae75d-93da-7a5a-e063-6394a90ac0c0 | 2024-12-24 | Boxed warning, Warnings, Adverse reactions | 207625 ANDA207625 |
| Levalbuterol | LEVALBUTEROL | Aurobindo Pharma Limited | 5f1c4f22-d420-495c-8f64-33532638215f | 2024-12-24 | Boxed warning, Warnings, Adverse reactions | 207625 ANDA207625 65862-944 65862-945 65862-943 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 65862-943 | Levalbuterol | Levalbuterol | Aurobindo Pharma Limited | ANDA | Current |
| 65862-943 | Levalbuterol | Levalbuterol | Aurobindo Pharma Limited | ANDA | Current |
| 65862-943 | Levalbuterol | Levalbuterol | Aurobindo Pharma Limited | ANDA | Current |
| 65862-943 | Levalbuterol | Levalbuterol | Aurobindo Pharma Limited | ANDA | Current |
| 65862-944 | Levalbuterol | Levalbuterol | Aurobindo Pharma Limited | ANDA | Current |
| 65862-944 | Levalbuterol | Levalbuterol | Aurobindo Pharma Limited | ANDA | Current |
| 65862-944 | Levalbuterol | Levalbuterol | Aurobindo Pharma Limited | ANDA | Current |
| 65862-944 | Levalbuterol | Levalbuterol | Aurobindo Pharma Limited | ANDA | Current |
| 65862-945 | Levalbuterol | Levalbuterol | Aurobindo Pharma Limited | ANDA | Current |
| 65862-945 | Levalbuterol | Levalbuterol | Aurobindo Pharma Limited | ANDA | Current |
| 65862-945 | Levalbuterol | Levalbuterol | Aurobindo Pharma Limited | ANDA | Current |
| 65862-945 | Levalbuterol | Levalbuterol | Aurobindo Pharma Limited | ANDA | Current |